Pharmanutra launches share buyback of up to 20,000 shares worth EUR 1.44 million

• Pharmanutra launched a share buyback program, citing first-half 2026 results and a share price seen as misaligned with fundamentals.
• Plan targets up to 20,000 ordinary shares for a maximum consideration of EUR 1.44 million.
• Purchases to be executed by Intermonte SIM within 18 months from the April 26, 2026 shareholder authorization.
• Pharmanutra held 105,794 treasury shares, equal to 1.09% of share capital, as of the announcement date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharmanutra S.p.A. published the original content used to generate this news brief via SDIR, the Italian regulatory disclosure system (Ref. ID: 20106-29-2026_TELEBORSA.pdf), on September 16, 2026, and is solely responsible for the information contained therein.